ACSG - ETF AI Analysis
Top Page
American Century Small Cap Growth Insights ETF (ACSG)
Rating:64Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and in recent months, showing solid momentum in its strategy.
Leading Holdings Performing Well
Many of the top positions, including several industrial and technology names, have shown strong year-to-date performance, helping drive the fund’s returns.
Broad Sector Diversification
The fund spreads its investments across many sectors, with meaningful exposure to industrials, health care, and technology, which helps reduce reliance on any single industry.
Negative Factors
Higher Expense Ratio for an ETF
The fund’s expense ratio is on the higher side for an ETF, which can modestly reduce net returns over time compared with lower-cost options.
Small Asset Base
The ETF manages a relatively small amount of assets, which can sometimes lead to wider trading spreads and a higher risk of the fund being closed in the future.
Heavy U.S. Concentration
With almost all assets invested in U.S. companies, the fund offers very limited geographic diversification and is highly tied to the U.S. market’s performance.
ACSG vs. SPDR S&P 500 ETF (SPY)
AUM25.52M
RegionNorth America
Expense Ratio0.49%
Beta1.20
IssuerAmerican Century
Inception DateOct 14, 2025
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume3,924
30 Day Avg. Volume4,600
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
60.65Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering312
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ACSG Summary
American Century Small Cap Growth Insights ETF (ACSG) is an actively managed fund that focuses on fast-growing smaller U.S. companies rather than following a set index. It spreads investments across areas like technology, health care, and industrials, and holds names such as Bloom Energy and Fabrinet. Someone might consider ACSG if they want long-term growth potential and diversification beyond the big, well-known large-cap stocks. However, small-cap growth stocks can be very volatile, so the value of this ETF can rise and fall more sharply than the overall market.
How much will it cost me?The American Century Small Cap Growth Insights ETF (ACSG) has an expense ratio of 0.49%, meaning you’ll pay $4.90 per year for every $1,000 invested. This cost is higher than average because the fund is actively managed, which involves more research and decision-making compared to passively managed ETFs that track an index.
What would affect this ETF?The ACSG ETF, focused on U.S. small-cap growth companies, could benefit from innovation and expansion in sectors like technology and healthcare, which make up a significant portion of its holdings. However, it may face challenges during economic downturns, as small-cap stocks are often more volatile and sensitive to interest rate hikes or reduced consumer spending. Regulatory changes or sector-specific disruptions could also impact its performance negatively.
ACSG Top 10 Holdings
ACSG is leaning hard into U.S. small-cap growth, with a clear tilt toward health care and tech names that can really move the needle. Crinetics Pharmaceuticals and 10x Genomics have been rising sharply, acting as the fund’s main engines despite ongoing profitability questions. On the industrial side, Argan and Plexus are steady climbers, helping smooth out the ride. CECO Environmental, however, has been lagging lately, putting a small drag on results. Overall, performance is driven by a handful of nimble, high-growth U.S. specialists rather than broad market giants.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Ceco Environmental | 0.97% | $247.32K | $4.67B | 149.78% | 72 Outperform | |
| Plexus | 0.90% | $230.14K | $6.71B | 85.94% | 75 Outperform | |
| Crinetics Pharmaceuticals | 0.88% | $225.21K | $8.88B | 169.56% | 61 Neutral | |
| Hexcel | 0.82% | $210.29K | $7.83B | 71.64% | 73 Outperform | |
| Esco Technologies | 0.80% | $204.03K | $8.25B | 62.31% | 70 Neutral | |
| AAR | 0.80% | $203.56K | $5.38B | 61.81% | 72 Outperform | |
| 10x Genomics | 0.78% | $199.58K | $5.55B | 260.00% | 60 Neutral | |
| OPENLANE | 0.77% | $196.25K | $4.18B | 56.22% | 70 Outperform | |
| Agilysys | 0.77% | $195.30K | $3.01B | -7.40% | 73 Outperform | |
| Argan | 0.73% | $187.25K | $7.73B | 166.79% | 73 Outperform |
ACSG Technical Analysis
Neutral
―
Price Trends
47.60
Positive
44.73
Positive
Market Momentum
0.41
Positive
50.02
Neutral
15.43
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ACSG, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 49.26, equal to the 50-day MA of 47.60, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.41 indicates Positive momentum. The RSI at 50.02 is Neutral, neither overbought nor oversold. The STOCH value of 15.43 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ACSG.
ACSG Peer Comparison
Comparison Results
Performance Comparison
ACSG
American Century Small Cap Growth Insights ETF
48.57
8.52
21.27%
TMFS
Motley Fool Small-Cap Growth ETF
―
―
―
MMSC
First Trust Multi-Manager Small Cap Opportunities ETF
―
―
―
SAWS
AAM Sawgrass US Small Cap Quality Growth ETF
―
―
―
FSEG
Fidelity Enhanced Small Cap Growth ETF
―
―
―
SGRW
Harbor Active Small Cap Growth ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents